Replies to post #125286 on Vivos Inc (RDGL)

[bdvest]

yes, do your DD, the work was published on a decent journal:
Cancer Biotherapy & Radiopharmaceuticals
https://www.liebertpub.com/doi/10.1089/cbr.2019.2947
This is the milestone of VIVOS, the word is spreading and new investors is buying the shares, there won't lots of cheapies there. when the Reg A funding finishes, RDGL is going much higher level and company will focus on IDE to get human trials started.